<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1130-6343</journal-id>
<journal-title><![CDATA[Farmacia Hospitalaria]]></journal-title>
<abbrev-journal-title><![CDATA[Farm Hosp.]]></abbrev-journal-title>
<issn>1130-6343</issn>
<publisher>
<publisher-name><![CDATA[Grupo Aula Médica]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1130-63432018000400174</article-id>
<article-id pub-id-type="doi">10.7399/fh.11064</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Life medicalization and the recent appearance of &#8220;pharmaceuticalization&#8221;]]></article-title>
<article-title xml:lang="es"><![CDATA[La medicalización de la vida y la reciente emergencia de la &#8220;medicamentalización&#8221;]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Meneu]]></surname>
<given-names><![CDATA[Ricard]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Fundación Instituto de Investigación en Servicios de Salud  ]]></institution>
<addr-line><![CDATA[Valencia ]]></addr-line>
<country>Spain</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>08</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>08</month>
<year>2018</year>
</pub-date>
<volume>42</volume>
<numero>4</numero>
<fpage>174</fpage>
<lpage>179</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S1130-63432018000400174&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S1130-63432018000400174&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S1130-63432018000400174&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract Medicalization is a concern to which we have been paying attention intermittently for the past half century. However, it is increasingly difficult to look away from its multiple and ubiquitous manifestations, and therefore there is an increasingly higher number of analysis and studies about them, from the most varied perspectives, not only by healthcare literature, but also with the great contribution by social sciences such as Anthropology or Sociology. Based on previous publications, this article offers an updated review on life medicalization in the European setting, highlighting particularly those situations where a medication is the main vehicle for medicalization. This demands a careful exploration of the &#8220;pharmaceuticalization&#8221; concept, which appeared in the past decade, and which many of the research projects with these characteristics intend to embrace. The decentralized nature of the decisions on diagnosis and treatment requires an agreement of healthcare professionals on the presumed benefits of certain therapeutic interventions as key factor to the expansion of medicalization. Even so, there are multiple interactions and synergies between incentives and economic interests in the medicalization process, as well as bias in the generation of knowledge, the training for professionals, their need to cope with patient expectations, progressively overcoming their resolution capacities, and the mechanisms for structuring said expectations. A better understanding of the dispositifs that promote medicalization (the strategy without a strategist that becomes visible through its cumulative outcome, but is less clearly seen by the different agents, sometimes contradictory, working through it) is essential in order to limit its most undesirable expansions.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen La medicalización es una preocupación a la que prestamos atención intermitentemente desde hace medio siglo, pero cada vez resulta más difícil apartar la mirada de sus múltiples y ubicuas manifestaciones. Los análisis y estudios sobre este fenómeno son cada vez más abundantes y adoptan perspectivas más variadas, no solo desde la literatura de matriz sanitaria sino también con importantes contribuciones de las ciencias sociales como la antropología o la sociología. A partir de trabajos previos se aporta una revisión actualizada sobre la medicalización de la vida en el entorno europeo, con especial énfasis en aquellas situaciones en las que un medicamento es el principal vehículo de la medicalización. Ese énfasis obliga a explorar atentamente el concepto de &#8220;medicamentalización&#8221; surgido en la década pasada, y al que se pretenden acoger muchas de las investigaciones de esas características. El carácter desconcentrado de las decisiones sobre diagnóstico y tratamiento exige para la extensión de la medicalización la anuencia de los sanitarios sobre los beneficios de las intervenciones terapéuticas. Aun así, en el proceso de medicalización las interacciones y sinergias son múltiples entre los incentivos e intereses económicos, los sesgos en la producción del conocimiento, la formación de los profesionales, su necesidad de lidiar con las expectativas de los pacientes, progresivamente alejadas de las capacidades de resolución de aquellos, y los mecanismos de conformación de dichas expectativas. Una mejor comprensión de los dispositivos que propician la medicalización -la estrategia sin un estratega que se hace visible a través de su resultado acumulativo, pero es vista con menos claridad por los diversos agentes, a veces contradictorios, que trabajan a través de él- resulta imprescindible para limitar sus extensiones más indeseables.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Medicalization]]></kwd>
<kwd lng="en"><![CDATA[Pharmaceuticalization]]></kwd>
<kwd lng="en"><![CDATA[Overutilization]]></kwd>
<kwd lng="en"><![CDATA[Overdiagnosis]]></kwd>
<kwd lng="en"><![CDATA[Overtreatment]]></kwd>
<kwd lng="en"><![CDATA[Agents]]></kwd>
<kwd lng="en"><![CDATA[Drivers]]></kwd>
<kwd lng="es"><![CDATA[Medicalización]]></kwd>
<kwd lng="es"><![CDATA[Medicamentalización]]></kwd>
<kwd lng="es"><![CDATA[Sobreutilización]]></kwd>
<kwd lng="es"><![CDATA[Sobrediagnóstico]]></kwd>
<kwd lng="es"><![CDATA[Sobretratamiento]]></kwd>
<kwd lng="es"><![CDATA[Agentes]]></kwd>
<kwd lng="es"><![CDATA[Motores]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Márquez]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Meneu]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La medicalización de la vida y sus protagonistas]]></article-title>
<source><![CDATA[Gest Clin Sanit]]></source>
<year>2003</year>
<volume>5</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>47-53</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Illich]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medical Nemesis]]></article-title>
<source><![CDATA[The Expropriation of Health]]></source>
<year>1975</year>
<publisher-loc><![CDATA[London ]]></publisher-loc>
<publisher-name><![CDATA[Calder &amp; Boyars]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Illich]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[L&#8217;obsession de la santé parfaite]]></article-title>
<source><![CDATA[Le Monde diplomatique]]></source>
<year>1999</year>
<page-range>28</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Birrer]]></surname>
<given-names><![CDATA[RB]]></given-names>
</name>
<name>
<surname><![CDATA[Tokuda]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medicalization: A historical perspective]]></article-title>
<source><![CDATA[J Gen Fam Med]]></source>
<year>2017</year>
<volume>18</volume>
<page-range>48-51</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Busfield]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Concept of Medicalisation Reassessed]]></article-title>
<source><![CDATA[Sociol Health Illn]]></source>
<year>2017</year>
<volume>39</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>759-74</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Faraone]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Barcala]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bianchi]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Torricelli]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La industria farmacéutica en los procesos de medicalización / medicamentalización en la infancia]]></article-title>
<source><![CDATA[Rev Electr Margen]]></source>
<year>2009</year>
<volume>54</volume>
</nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Clarke]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
<name>
<surname><![CDATA[Shim]]></surname>
<given-names><![CDATA[JK]]></given-names>
</name>
<name>
<surname><![CDATA[Mamo]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Fosket]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Fishman]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Biomedicalization: Technoscientific Transformations of Health, Illness, and U.S. Biomedicine]]></article-title>
<source><![CDATA[Am Sociol Rev]]></source>
<year>2003</year>
<volume>68</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>161-94</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arribas-Ayllon]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[After geneticization]]></article-title>
<source><![CDATA[Soc Sci Med]]></source>
<year>2016</year>
<volume>159</volume>
<page-range>132-9</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kishore]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[A dictionary of Public Health]]></source>
<year>2002</year>
<publisher-loc><![CDATA[New Delhi ]]></publisher-loc>
<publisher-name><![CDATA[Century Publications]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Porta]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[A dictionary of epidemiology]]></source>
<year>2014</year>
<edition>Sixth edition</edition>
<publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[OUP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Welch]]></surname>
<given-names><![CDATA[HG]]></given-names>
</name>
<name>
<surname><![CDATA[Schwartz]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Woloshin]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[Overdiagnosed: Making people sick in the pursuit of health]]></source>
<year>2011</year>
<publisher-loc><![CDATA[Boston ]]></publisher-loc>
<publisher-name><![CDATA[Beacon Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hofmann]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medicalization and overdiagnosis: different but alike]]></article-title>
<source><![CDATA[Med Health Care Philos]]></source>
<year>2016</year>
<volume>19</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>253-64</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brownlee]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[Overtreated. Why Too Much Medicine Is Making Us Sicker and Poorer]]></source>
<year>2007</year>
<publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[Bloomsbury Publishing]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Van Dijk]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Faber]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Tanke]]></surname>
<given-names><![CDATA[MAC]]></given-names>
</name>
<name>
<surname><![CDATA[Jeurissen]]></surname>
<given-names><![CDATA[PPT]]></given-names>
</name>
<name>
<surname><![CDATA[Westert]]></surname>
<given-names><![CDATA[GP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medicalisation and Overdiagnosis: What Society Does to Medicine]]></article-title>
<source><![CDATA[Int J Health Policy Manag]]></source>
<year>2016</year>
<volume>5</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>619-22</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Conrad]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Schneider]]></surname>
<given-names><![CDATA[JW]]></given-names>
</name>
</person-group>
<source><![CDATA[Deviance and Medicalization: From Badness to Sickness]]></source>
<year>1992</year>
<publisher-loc><![CDATA[Philadelphia ]]></publisher-loc>
<publisher-name><![CDATA[Temple University Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barsky]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Borus]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Somatization and Medicalization in the Era of Managed Care]]></article-title>
<source><![CDATA[J Am Med Assoc]]></source>
<year>1995</year>
<volume>274</volume>
<page-range>1931-4</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Broom]]></surname>
<given-names><![CDATA[DH]]></given-names>
</name>
<name>
<surname><![CDATA[Woodward]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medicalisation reconsidered: toward a collaborative approach to care]]></article-title>
<source><![CDATA[Soc Health Illn]]></source>
<year>1996</year>
<volume>18</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>357-78</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Foucault]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Power, Truth, Strategy]]></source>
<year>1979</year>
<publisher-loc><![CDATA[Sidney ]]></publisher-loc>
<publisher-name><![CDATA[Feral Publications]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Foucault]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Power/Knowledge. Selected Interviews and Other Writings 1972-1977]]></source>
<year>1980</year>
<publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[Pantheon Books]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Conrad]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Foreword]]></article-title>
<source><![CDATA[Reimagining Bio-Medicalization, Pharmaceuticals and Genetics- Old Critiques New engagements]]></source>
<year>2015</year>
<publisher-loc><![CDATA[London ]]></publisher-loc>
<publisher-name><![CDATA[Routledge]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Davies]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Drugs, cancer and end-of-life care: a case study of pharmaceuticalization?]]></article-title>
<source><![CDATA[Soc Sci Med]]></source>
<year>2015</year>
<volume>131</volume>
<page-range>207-14</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gabe]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Williams]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Coveney]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmaceuticals and society: Power, promises and prospects]]></article-title>
<source><![CDATA[Soc Sci Med]]></source>
<year>2015</year>
<volume>131</volume>
<page-range>193-8</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cooperstock]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Lennard]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Some social meanings of tranquilliser use]]></article-title>
<source><![CDATA[Sociol Health Illn]]></source>
<year>1979</year>
<volume>1</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>331-47</page-range></nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gabe]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Understanding Tranquilliser Use]]></source>
<year>1991</year>
<publisher-loc><![CDATA[London ]]></publisher-loc>
<publisher-name><![CDATA[Routledge]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abraham]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Sheppard]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[The Therapeutic Nightmare]]></source>
<year>1999</year>
<publisher-loc><![CDATA[London ]]></publisher-loc>
<publisher-name><![CDATA[Earthscan]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gabe]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bury]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Halcion nights: a sociological account of a medical controversy]]></article-title>
<source><![CDATA[Sociology]]></source>
<year>1996</year>
<volume>30</volume>
<page-range>447-69</page-range></nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Koumjian]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The use of valium as a form of social control]]></article-title>
<source><![CDATA[Soc Sci Med]]></source>
<year>1981</year>
<volume>15</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>245-9</page-range></nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Conrad]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<source><![CDATA[The medicalization of society. On the transformation of human conditions into treatable disorders]]></source>
<year>2007</year>
<publisher-loc><![CDATA[Baltimore ]]></publisher-loc>
<publisher-name><![CDATA[The Johns Hopkins University Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nichter]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmaceuticals, the commodification of health, and the health caremedicine use transition]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Nichter]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Nichter]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Anthropology and International Health: Asian Case Studies]]></source>
<year>2003</year>
<page-range>268-333</page-range><publisher-loc><![CDATA[London ]]></publisher-loc>
<publisher-name><![CDATA[Routledge]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B30">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abraham]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmaceuticalization of society in context: theoretical, empirical and health dimensions]]></article-title>
<source><![CDATA[Sociology]]></source>
<year>2010</year>
<volume>44</volume>
<page-range>603-22</page-range></nlm-citation>
</ref>
<ref id="B31">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Williams]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Gabe]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Pharmaceuticalisation of Society? A Frame for Analysis]]></article-title>
<source><![CDATA[Sociol Health Illn]]></source>
<year>2011</year>
<volume>33</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>710-25</page-range></nlm-citation>
</ref>
<ref id="B32">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Williams]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Gabe]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evolving sociological analyses of &#8216;Pharmaceuticalisation&#8217;: a reply to Abraham]]></article-title>
<source><![CDATA[Sociol Health Illn]]></source>
<year>2011</year>
<volume>33</volume>
<numero>5</numero>
<issue>5</issue>
</nlm-citation>
</ref>
<ref id="B33">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Elam]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmaceutical Incursion on Cigarette Smoking at the Birth of the Brain Disease Model of Addiction]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Netherland]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Critical Perspectives on Addiction: Advances in Medical Sociology]]></source>
<year>2012</year>
<publisher-loc><![CDATA[London ]]></publisher-loc>
<publisher-name><![CDATA[Emerald Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B34">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Illich]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<source><![CDATA[Limits to Medicine/Medical Nemesis: The Expropriation of Health]]></source>
<year>1976</year>
<publisher-name><![CDATA[Marion Boyars]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B35">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Sjögren]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Åsberg]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[Glocal Pharma. International brands and the imagination of local masculinity]]></source>
<year>2016</year>
<publisher-loc><![CDATA[London ]]></publisher-loc>
<publisher-name><![CDATA[Routledge]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B36">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Williams]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Coveney]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Gabe]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The concept of medicalisation reassessed: a response to Joan Busfield]]></article-title>
<source><![CDATA[Sociol Health Illn]]></source>
<year>2017</year>
<volume>39</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>775-80</page-range></nlm-citation>
</ref>
<ref id="B37">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Conrad]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<source><![CDATA[The medicalization of society: On the transformation of human conditions into treatable disorders]]></source>
<year>2007</year>
<publisher-loc><![CDATA[Baltimore ]]></publisher-loc>
<publisher-name><![CDATA[Johns Hopkins University Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B38">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Busfield]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The concept of medicalisation reassessed]]></article-title>
<source><![CDATA[Sociol Health Illn]]></source>
<year>2017</year>
<volume>39</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>759-74</page-range></nlm-citation>
</ref>
<ref id="B39">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zola]]></surname>
<given-names><![CDATA[IK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medicine as an institution of social control]]></article-title>
<source><![CDATA[Sociol Rev]]></source>
<year>1972</year>
<volume>20</volume>
<page-range>487-504</page-range></nlm-citation>
</ref>
<ref id="B40">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Greene]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Vital Objects: Essential Drugs and Their Critical Legacies]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Bell]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Figert]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
</person-group>
<source><![CDATA[Reimagining (Bio)Medicalization, Pharmaceuticals and Genetics: Old Critiques and New Engagements]]></source>
<year>2015</year>
<publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[Routledge]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B41">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fishman]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The making of Viagra: the biomedicalization of sexual dysfunction]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Clarke]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Biomedicalization: technoscience, health and illness in the U.S]]></source>
<year>2010</year>
<publisher-loc><![CDATA[Durkham ]]></publisher-loc>
<publisher-name><![CDATA[Duke University Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B42">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moynihan]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Mintzes]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<source><![CDATA[Sex, lies and pharmaceuticals: how drug companies plan to profit from female sexual dysfunction]]></source>
<year>2010</year>
<publisher-loc><![CDATA[Vancouver ]]></publisher-loc>
<publisher-name><![CDATA[Greystone]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B43">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Krieger]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Löwy]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Aronowitz]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hormone replacement therapy, cancer, controversies, and women&#8217;s health: historical, epidemiological, biological, clinical, and advocacy perspectives]]></article-title>
<source><![CDATA[J Epidemiol Community Health]]></source>
<year>2005</year>
<volume>59</volume>
<page-range>740-74</page-range></nlm-citation>
</ref>
<ref id="B44">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Söderfeldt]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Droppe]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ohnhäuser]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Distress, disease, desire: perspectives on the medicalisation of premature ejaculation]]></article-title>
<source><![CDATA[J Med Ethics]]></source>
<year>2017</year>
<volume>43</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>865-6</page-range></nlm-citation>
</ref>
<ref id="B45">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Unruh]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Rice]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Vaillancourt Rosenau]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The 2013 cholesterol guideline controversy: Would better evidence prevent pharmaceuticalization?]]></article-title>
<source><![CDATA[Health Policy]]></source>
<year>2016</year>
<volume>120</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>797-808</page-range></nlm-citation>
</ref>
<ref id="B46">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wyatt]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medicalization of Depression, Anxiety, Schizophrenia, ADHD, Childhood Bipolar Disorder and Tantrums: Scientific Breakthrough, or Broad-Based Delusion?]]></article-title>
<source><![CDATA[Post N Med]]></source>
<year>2013</year>
<volume>26</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>10-21</page-range></nlm-citation>
</ref>
<ref id="B47">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Conrad]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<source><![CDATA[Identifying hyperactive children: the medicalization of deviant behavior]]></source>
<year>1976</year>
<publisher-loc><![CDATA[Lexington ]]></publisher-loc>
<publisher-name><![CDATA[Lexington Books]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B48">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Conrad]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Bergey]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The impending globalization of ADHD: Notes on the expansion and growth of a medicalized disorder]]></article-title>
<source><![CDATA[Soc Sci Med]]></source>
<year>2014</year>
<volume>122</volume>
<page-range>31-43</page-range></nlm-citation>
</ref>
<ref id="B49">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cosgrove]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Krimsky]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A Comparison of DSM-IV and DSM-5 Panel Members&#8217; Financial Associations with Industry: A Pernicious Problem Persists]]></article-title>
<source><![CDATA[PLoS Med]]></source>
<year>2012</year>
<volume>9</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B50">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Barrett]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Sisti]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The ethical boundaries of patient and advocate influence on DSM-5]]></article-title>
<source><![CDATA[Harv Rev Psychiatry]]></source>
<year>2013</year>
<volume>21</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>334-44</page-range></nlm-citation>
</ref>
<ref id="B51">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hofmann]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Limits to human enhancement: nature, disease, therapy or betterment?]]></article-title>
<source><![CDATA[BMC Med Ethics]]></source>
<year>2017</year>
<volume>18</volume>
<page-range>56</page-range></nlm-citation>
</ref>
<ref id="B52">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morrison]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Growth hormone, enhancement and the pharmaceuticalisation of short stature]]></article-title>
<source><![CDATA[Soc Sci Med]]></source>
<year>2015</year>
<volume>131</volume>
<page-range>305-12</page-range></nlm-citation>
</ref>
<ref id="B53">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Davis]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Naci]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Gurpinar]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Poplavska]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Pinto]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Aggarwal]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13]]></article-title>
<source><![CDATA[BMJ]]></source>
<year>2017</year>
<volume>359</volume>
</nlm-citation>
</ref>
<ref id="B54">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mende]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Trautmann]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Rentsch]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Hornemann]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Schuler]]></surname>
<given-names><![CDATA[US]]></given-names>
</name>
<name>
<surname><![CDATA[Ehninger]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patients&#8217; perspective on palliative chemotherapy of colorectal and non-colorectal cancer: a prospective study in chemotherapy-exposed population]]></article-title>
<source><![CDATA[BMC Cancer]]></source>
<year>2013</year>
<page-range>13:66</page-range></nlm-citation>
</ref>
<ref id="B55">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barnes]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Groskaufmanis]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Thomson III]]></surname>
<given-names><![CDATA[NB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Promising Approaches From Behavioral Economics to Improve Patient Lung Cancer Screening Decisions]]></article-title>
<source><![CDATA[J Am Coll Radiol]]></source>
<year>2016</year>
<volume>13</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1566-70</page-range></nlm-citation>
</ref>
<ref id="B56">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Andrew]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Vickers]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[O&#8217;Connor]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Valdes]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Tang]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Media Reporting of Practice-Changing Clinical Trials in Oncology: A North American Perspective]]></article-title>
<source><![CDATA[Oncologist]]></source>
<year>2016</year>
<volume>21</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>269-78</page-range></nlm-citation>
</ref>
<ref id="B57">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fishman]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ten Have]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Casarett]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cancer and the media. How does the news report on treatment and outcomes?]]></article-title>
<source><![CDATA[Arch Intern Med]]></source>
<year>2010</year>
<volume>170</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>515-8</page-range></nlm-citation>
</ref>
<ref id="B58">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lewison]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Tootell]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Roe]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Sullivan]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[How do the media report cancer research? A study of the UK&#8217;s BBC website]]></article-title>
<source><![CDATA[Br J Cancer]]></source>
<year>2008</year>
<volume>99</volume>
<page-range>569-76</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
